Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Scientific Reports volume 14, Article number: 31542 (2024 ) Cite this article sensor gas detector
Helicobacter pylori (H. pylori) is one of the most globally prevalent bacteria, closely associated with gastrointestinal diseases such as gastric ulcers and chronic gastritis. Current clinical methods primarily involve Carbon-13 and Carbon-14 urea breath test, both carrying potential safety risks. Fourier-transform infrared (FTIR) spectroscopy can detect human exhaled gases, which may change under disease conditions. This preliminary study aims to explore the application value of FTIR-based breath analysis in detecting H. pylori infection, providing theoretical basis and clinical references for new clinical detection methods. A cross-sectional survey was conducted from August 2021 to May 2022 at Renmin Hospital of Wuhan University. Breath samples were collected before and half an hour after ingesting unlabeled urea. Gas samples were analyzed using FTIR breath spectra. Individual exhalation spectral data after deducting baseline spectral data were used as the basis for the training and test sets through K-center clustering algorithm. Results: A total of 278 samples were collected (63 H. pylori infection cases, 215 healthy controls). There were no statistically significant differences in general data (age, gender, smoking history, alcohol consumption history, comorbidities, etc.) between the two groups. The predictive model was successfully established, with recognition rates of 94.12%, 98.39%, and 91.30% for the training set, test set, and validation set, respectively. Exhaled gas analysis based on Fourier-transform infrared spectroscopy has the potential to diagnose H. pylori infection.
Helicobacter pylori (H. pylori) is a Gram-negative bacterium that colonizes human gastric mucosal epithelial cells1. Infection with H. pylori is closely associated with gastric ulcers, chronic gastritis, duodenal ulcers, and prolonged infection can lead to gastric cancer2. H. pylori has a global infection rate of over half the world’s population, making it one of the most prevalent bacterial infections3. China is a country with a high H. pylori infection rate. A large, national epidemiologic study in 2023 showed an average individual-based prevalence of H. pylori infection of 40.66%, 43.45% in adults, and 20.55% in children and adolescents4. Therefore, early diagnosis and treatment of H. pylori infection are crucial. Currently, it is widely believed that H. pylori can be transmitted via "human-to-human," "fecal–oral," or “endoscopic” routes, exhibiting a clear familial aggregation phenomenon5. The diagnosis of H. pylori can be divided into invasive and non-invasive methods (which do not require endoscopy). The former includes pathological examination and serological diagnosis, while the latter mainly involves the 13C or 14C-urea breath test (UBT)6. In clinical practice, 13C or 14C breath tests are predominantly used. The principle of this test is based on isotopically labeled urea being ingested by the patient, which is then broken down by urease produced by H. pylori, generating 13CO2. This 13CO2 diffuses through epithelial cells, is absorbed by the bloodstream, and is exhaled through the lungs7. Therefore, it carries a small amount of radioactivity, posing potential safety risks to patients. Consequently, researchers are exploring new diagnostic methods such as Surface-Enhanced Raman Spectroscopy (SERS)8, biosensor technology9, and metagenomic sequencing10. Compared to these novel diagnostic approaches, breath detection offers advantages such as non-invasiveness, non-intrusiveness, and rapid convenience. In summary, the development of a new breath test method for H. pylori that is radiation-free and highly safe holds great promise.
Exhaled breath detection provides a non-invasive approach for identifying disease biomarkers and monitoring patient health in the field of medical diagnostics. This method relies on the analysis of endogenous volatile organic compounds (VOCs). Endogenous VOCs are byproducts or end-products of human or microbial metabolism and can be detected in exhaled breath, sweat, blood, tissue samples, urine, and feces11,12. Exhaled VOCs include molecules such as alkanes, benzene derivatives, acetone, dimethyl sulfide, phenol, and aromatic compounds13. A growing body of research indicates that certain diseases and infections can lead to characteristic changes in exhaled VOCs, such as esophageal cancer14, colorectal cancer15, and inflammatory bowel disease16. Apart from the UBT, novel breath analysis technologies, such as the graphene-based high-sensitivity electronic nose17, are being investigated for the diagnosis of H. pylori infection. However, related research in this area remains limited at present.
Fourier-transform infrared (FTIR) spectroscopy is an analytical technique used to analyze the spectral characteristics of various solids, liquids, and gases18. This technology measures the absorption of infrared light by molecular bonds in biological samples, generating a unique “fingerprint” spectrum that reflects the molecular composition of the sample. The sensitivity of FTIR to biochemical changes enables researchers to apply it to the diagnosis of various diseases, including cancer and metabolic disorders. In cancer detection, FTIR has been employed to analyze blood, urine, and tissue samples, with existing studies highlighting its potential in identifying early-stage tumors, making it a promising tool for non-invasive cancer diagnosis19,20,21. The application of FTIR has also extended to metabolic diseases such as diabetes, where it can detect glucose and other metabolic byproducts in blood and saliva samples22,23. In recent years, FTIR spectroscopy has emerged as a promising breath analysis technology for disease detection. It has been applied to detect infectious diseases such as SARS-CoV-224 and respiratory conditions like asthma and COPD25, demonstrating significant potential. However, no studies to date have explored the use of FTIR-based exhaled breath analysis for the diagnosis of H. pylori.
Based on this, our study employs FTIR spectroscopy to analyze the exhaled breath of patients with H. pylori infection before and after the ingestion of unlabeled urea. By comparing the breath spectra with those of a healthy control group, we use the K-means clustering algorithm to classify different sample types and establish a predictive model. This approach provides new insights and methods for using breath analysis in the diagnosis of H. pylori infection.
Gas collection bags (Shenzhen CNNC High-Tech Co., Ltd.); Nexus 870 Fourier Transform Infrared Spectrometer (Thermo Fisher Scientific, USA) with a spectral measurement range of 1.5–25 µm and a maximum resolution of 0.4 cm⁻1; high-purity nitrogen gas.
The gas cell, serving as the carrier for sample gas testing, must meet the wavelength measurement range requirements while also possessing a stable mechanical structure, interference resistance, and appropriate volume. The volume of the gas collection bag determines the gas cell volume. The volume of the gas collection bag is 100 ml; therefore, the gas cell is best designed with a volume of approximately 20 ml to ensure sufficient sample gas for testing. Assuming the gas cell has an optical path length of 10 cm and an inner diameter of 1.6 cm, the calculated volume is 20.096 ml, meeting the design requirements. The windows of the gas cell need to accommodate a broad wavelength transmission range, as different materials transmit light across varying spectral ranges. Based on project requirements and to obtain more spectral data, potassium bromide was chosen as the material for the windows.
This study was conducted at the Digestive Endoscopy Center of Renmin Hospital of Wuhan University from August 2021 to May 2022, with a total collection of 330 exhaled breath samples. The Ethics Committee of Wuhan University People’s Hospital has approved this single center research project, which was conducted in accordance with the principles of the Helsinki Declaration. A written informed consent was obtained from all participants. After excluding abnormal samples, 278 samples were included in the study. Among them, 63 patients infected with H. pylori were defined as the disease group. The healthy control group consisted of 215 individuals, including 46 who had been cured of H. pylori infection. All subjects signed an information survey form and informed consent before sample collection. The inclusion criteria for study subjects were: (1) Individuals were definitively diagnosed with or without H. pylori infection using the 13C-UBT. (2) Informed consent to participate in this study. Exclusion criteria included: (1) A history of antibiotic and proton pump inhibitor use within 1 month before the test. (2) Presence of mental disorders. (3) Suffering from oral, nasopharyngeal, or respiratory diseases such as dental caries, periodontitis, pharyngitis, or lung cancer. (4) Suffering from infectious respiratory diseases such as tuberculosis or COVID-19.
Pre-sampling Requirements: Subjects fasted for at least 8 h before sampling.
Rest and Sampling Procedure: Subjects were required to rest in the sampling area for at least 20 min before sampling. The collection of breath samples was conducted immediately before endoscopy or surgery. After taking three deep breaths and holding their breath for 10 s (inhale through the nose and exhale through the mouth), subjects exhaled into the gas collection bag using a disposable mouthpiece.
Sample Collection Timeline: One bag of exhaled breath was collected before urea intake, and another bag was collected half an hour after urea intake.
Sample Handling and Analysis: After the collection of exhaled breath samples, each sample was labeled and stored in a light-proof, temperature-controlled box. Samples were transported back to the laboratory within 2 h and analyzed within 24 h.
A high-precision gas cell with a broad spectral measurement range was fixed inside the sample compartment of the Fourier Transform Infrared Spectrometer. The gas sample from the collection bag was introduced into the gas cell for measurement through negative pressure suction. The gas cell’s inlet was connected to the collection bag via an electromagnetic valve, and the outlet was connected to a vacuum pump through another electromagnetic valve. The gas extracted by the vacuum pump was discharged outdoors through a gas wash bottle. The vacuum pump was used to achieve a vacuum level of 10 kPa, with 10% of the gas remaining after each vacuum cycle. Before each measurement, the system was evacuated and rinsed: first with nitrogen gas, then twice with the sample gas to ensure that residual sample gas was less than 0.1% and nitrogen gas greater than 0.9%. This procedure was performed to avoid cross-interference between samples and to ensure the purity of the sample gas.
Clinical data were entered and organized using Excel 2019. Statistical analyses were performed using SPSS 26.0 software. Measurement data conforming to a normal distribution were expressed as mean values, and comparisons between groups were conducted using the t-test. Categorical data were presented as frequencies and percentages, with comparisons between groups performed using the chi-square test. A p-value of less than 0.05 was considered statistically significant.
Given the numerous influencing factors, the exhaled breath spectral data before urea intake is used as the baseline. The foundational sample data is obtained by subtracting this baseline spectrum from the exhaled breath spectral data after consuming unlabeled urea. The specific subtraction formula used is:
A1 and A2 represent the spectra measured after and before taking the medication, respectivel.υ represents the wavenumber points, with a range of 542.7429–3959.744 cm⁻1.
The obtained spectral data were analyzed using Principal Component Analysis (PCA) to reduce complexity and enhance the density of useful information. Subsequently, the K-means clustering algorithm was used to classify different sample types and preliminarily construct various predictive models. These models were then analyzed for their recognition rate, as well as their accuracy, precision, sensitivity, and specificity on the training set. The final predictive model was determined based on these metrics, and its recognition rate was analyzed to further validate the diagnostic performance of FTIR in detecting H. pylori infection.
This study included 63 patients infected with H. pylori and 215 healthy controls. Statistical analysis of the clinical data showed no significant differences between the two groups in terms of age, gender, smoking history, alcohol consumption history, or comorbidities (P > 0.05) (The results are presented in Supplementary Table S1).
Figure 1 presents the preprocessed spectra of positive and negative samples. Based on extensive comparisons of positive and negative spectra, it was found that positive samples exhibit significant differences in the spectral bands at 930–970 cm−1 and 2350 cm−1. Through cross-referencing and analysis with various infrared standard gas molecule databases, these bands were identified as the absorption peaks of ammonia and carbon dioxide, respectively. In individuals infected with Helicobacter pylori, the ingestion of urea leads to its hydrolysis by urease, resulting in the production of ammonia and carbon dioxide. Consequently, this segment of the infrared spectrum was identified as the basis for subsequent qualitative and quantitative analyses.
Infrared difference preprocessed spectra comparison chart for positive and negative samples.
Within the wavenumber range of 1300–2000 cm⁻1, the “positive” line exhibits more pronounced “positive peaks” compared to the “negative” line, while the “negative” line shows more “negative peaks” in the same region. This difference is instrumental for distinguishing between the two in diagnostic discrimination models. In other wavenumber regions, variations in absorption intensity are also observed between the “positive” and “negative” lines, which further facilitates classification.
Based on the spectral data calculated from 141 exhaled breath samples of H. pylori infected patients and healthy individuals, the samples were categorized into a training set (70 samples), a test set (46 samples), and a validation set (25 samples) by applying the K-means clustering algorithm after PCA analysis. Subsequently, three models were constructed using Partial Least Squares (PLS), Support Vector Regression (SVR), and Extremely Randomized Trees (ERT) algorithms. The model with the highest accuracy was selected as the final diagnostic model based on usability criteria. Validation testing was then performed using the accuracy of positive-to-negative conversion samples to evaluate the model’s performance with new samples.
As shown in Table 1, among the three models, SVR and ERT demonstrated higher recognition rates for the test set, training set, and validation set. Specifically, the recognition rate of SVR reached 100% for the test set, while ERT achieved 100% for the validation set. Furthermore, when evaluating the diagnostic performance of the three machine learning models on the test set, the accuracy, precision, sensitivity, and specificity of all three models were suboptimal, with ERT showing the best diagnostic ability. Its accuracy reached 89.13%, with good specificity, sensitivity, and precision (Table 2).
Based on the spectral data calculated from a total of 278 exhaled breath samples from H. pylori infected patients and healthy individuals, the K-means clustering algorithm was used to divide the training set with 170 samples, the test set with 62 samples and the validation set with 46 samples. Considering the diagnostic performance of the three aforementioned machine learning models, the final predictive model was constructed using Partial Least Squares Discriminant Analysis (PLS-DA).
As shown in Table 3, the recognition rates of the predictive model for the training set, test set, and validation set were 94.12%, 98.39%, and 91.30%, respectively (Fig. 2). Therefore, the PLS-DA machine learning model based on pre- and post-medication spectral data demonstrates significant potential in diagnosing H. pylori infection.
Final predictive model breath test differential diagnosis results chart.
Several diagnostic methods for H. pylori infection have been developed, including invasive tests and non-invasive tests, such as serological tests, stool antigen tests for H. pylori, and UBT. Among non-invasive methods, the 13C-UBT has been proven to be one of the most accurate diagnostic methods for detecting H. pylori infection in both adults and children26,27. Compared to biopsy, the sensitivity and specificity of UBT have been demonstrated to range between 90 and 100%, making it the clinical diagnostic gold standard. Currently, the analysis of 13CO2 in breath samples is conducted using a highly sensitive (up to 0.01‰) but expensive and complex system based on isotope ratio mass spectrometry (IRMS)28. Therefore, this diagnostic method has drawbacks such as high cost, time-consuming operation, and potential health risks to the human body. In addition to the non-invasive UBT, laboratory serological methods such as ELISA tests, latex agglutination assays, and immunochromatographic tests, as well as H. pylori stool antigen (HpSA) detection, are widely used and represent advanced diagnostic techniques29. Researchers are also actively developing innovative diagnostic approaches that are convenient, safe, and rapid, including novel breath testing methods. Studies utilizing gas chromatography-mass spectrometry (GC–MS) for detecting H. pylori infection highlight the promising potential of these new breath analysis techniques30.A preliminary clinical study has, for the first time, employed an innovative point-contact nanosensor device based on the organic conductor tetracyanoquinodimethane (TCNQ) to identify differences in breath characteristics between H. pylori-positive and H. pylori-negative adolescents with functional dyspepsia. Furthermore, this study demonstrates encouraging potential in distinguishing pathogenic H. pylori strains from non-pathogenic ones31.
There is limited research on the application of FTIR Spectroscopy in breath analysis of H. pylori detection. Research has utilized FTIR spectroscopy in 13C-labeled UBT, allowing highly specific measurements of 13C enrichment in breath samples32. A study utilizing infrared spectroscopy to analyze exhaled breath, particularly by detecting specific biomarkers, effectively tracked the biochemical changes associated with antibiotic treatment in H. pylori patients33, demonstrating the advantages of FTIR in breath analysis. This study focuses on the use of FTIR to compare exhaled breath before and after non-labeled urea intake in 63 H. pylori infected patients and 215 healthy individuals (including 46 subjects who had been cured of H. pylori infection). The predictive model constructed using PLS-DA achieved recognition rates of 94.12%, 98.39%, and 91.30% for the training set, test set, and validation set, respectively. Currently, research on novel diagnostic methods for H. pylori infection is advancing in two major directions. The first focuses on developing more precise and detailed diagnostic techniques. For instance, one approach employs label-free SERS spectroscopy of serum combined with deep learning to analyze H. pylori infection. This method classifies infections into two types based on the presence of CagA and VacA toxins in serum: carcinogenic Type I infection and non-carcinogenic Type II infection34. Another study integrates endoscopic examination with intraoperative gastric fluid analysis to detect H. pylori infection, followed by antibiotic susceptibility testing for patients with positive results35. This approach aids in tailoring eradication strategies for H. pylori infections. In comparison, the detection method adopted in this study demonstrates significant advantages in non-invasiveness, safety, and convenience, although its diagnostic accuracy requires improvement. Future efforts will focus on expanding the sample size and enhancing the diagnostic model’s accuracy. The second direction emphasizes the development of rapid, non-invasive, and user-friendly diagnostic techniques. For example, a recent study employed a portable, handheld ammonia sensor to detect H. pylori infection36. In comparison, this study’s method analyzes a broader range of gas types, showcasing an advantage in multidimensional gas recognition. Moving forward, we aim to develop more portable and efficient detection devices to enhance the applicability and competitiveness of the method presented in this study.
This study establishes a method for diagnosing H. pylori infection without the use of isotopic breath tests, providing new insights and approaches for using breath analysis in the diagnosis of H. pylori infection. In future research, we plan to increase the sample size to enhance the accuracy of breath screening for H. pylori infection. Furthermore, we will continue to optimize and refine the experimental testing protocols and platform to ensure data quality, and directly analyze the compositional differences in exhaled breath between H. pylori-infected patients and healthy controls.
The original contributions presented in the study are included in the article/ Supplementary Material. Further inquiries can be directed to the corresponding author.
Umar, Z., et al. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings. Crit. Rev. Microbiol., 2024: p. 1–30.
Liou, J. M. et al. 40 years after the discovery of Helicobacter pylori: Towards elimination of H pylori for gastric cancer prevention. Lancet 403(10444), 2570–2572 (2024).
Article PubMed MATH Google Scholar
Hooi, J. K. Y. et al. Global prevalence of helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology 153(2), 420–429 (2017).
Article PubMed MATH Google Scholar
Zhou, X. Z. et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: The time to change practice for related disease prevention. Gut 72(5), 855–869 (2023).
Article PubMed MATH Google Scholar
Burucoa, C. & Axon, A. Epidemiology of Helicobacter pylori infection. Helicobacter 22(Suppl), 1 (2017).
Sun, Q. et al. Helicobacter pylori infection: a dynamic process from diagnosis to treatment. Front Cell Infect Microbiol 13, 1257817 (2023).
Article CAS PubMed PubMed Central Google Scholar
Sabbagh, P. et al. Diagnostic methods for Helicobacter pylori infection: Ideals, options, and limitations. Eur J Clin Microbiol Infect Dis 38(1), 55–66 (2019).
Article CAS PubMed MATH Google Scholar
Tang, J. W. et al. Detection of helicobacter pylori infection in human gastric fluid through surface-enhanced raman spectroscopy coupled with machine learning algorithms. Lab Invest 104(2), 100310 (2024).
Article PubMed MATH Google Scholar
Saxena, K., Chauhan, N. & Jain, U. Advances in diagnosis of Helicobacter pylori through biosensors: Point of care devices. Anal Biochem 630, 114325 (2021).
Article CAS PubMed MATH Google Scholar
Sorini, C., et al. Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals. JCI Insight, 2023. 8(4).
Blanchet, L. et al. Factors that influence the volatile organic compound content in human breath. J Breath Res 11(1), 016013 (2017).
Article MathSciNet CAS PubMed Google Scholar
Amann, A. et al. The human volatilome: Volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J Breath Res 8(3), 034001 (2014).
Article CAS PubMed Google Scholar
Dragonieri, S. et al. Electronic nose technology in respiratory diseases. Lung 195(2), 157–165 (2017).
Article CAS PubMed MATH Google Scholar
Markar, S. R. et al. Assessment of a noninvasive exhaled breath test for the diagnosis of oesophagogastric cancer. JAMA Oncol 4(7), 970–976 (2018).
Article PubMed PubMed Central MATH Google Scholar
Monedeiro, F., et al. A review of GC-based analysis of non-invasive biomarkers of colorectal cancer and related pathways. J. Clin. Med., 2020. 9(10).
Tiele, A., et al. Breath analysis using eNose and ion mobility technology to diagnose inflammatory bowel disease: A pilot study. Biosensors (Basel), 2019. 9(2).
Liu, X., et al. A prototype of graphene E-nose for exhaled breath detection and label-free diagnosis of helicobacter pylori infection. Adv. Sci. (Weinh), 2024: p. e2401695.
Greener, J., Abbasi, B. & Kumacheva, E. Attenuated total reflection Fourier transform infrared spectroscopy for on-chip monitoring of solute concentrations. Lab Chip 10(12), 1561–1566 (2010).
Article CAS PubMed MATH Google Scholar
Su, K. Y. and Lee, W. L. Fourier transform infrared spectroscopy as a cancer screening and diagnostic tool: A review and prospects. Cancers (Basel), 2020. 12(1).
Wang, R., Wang, Y. Fourier transform infrared spectroscopy in oral cancer diagnosis. Int. J. Mol. Sci., 2021. 22(3).
Delrue, C., et al. Infrared spectroscopy in gynecological oncology: A comprehensive review of diagnostic potentials and challenges. Int. J. Mol. Sci., 2024. 25(11).
Nogueira, M. S. et al. FTIR spectroscopy as a point of care diagnostic tool for diabetes and periodontitis: A saliva analysis approach. Photodiagnosis Photodyn Ther 40, 103036 (2022).
Article CAS PubMed MATH Google Scholar
Pang, W. et al. Serum-based ATR-FTIR spectroscopy combined with multivariate analysis for the diagnosis of pre-diabetes and diabetes. Analyst 149(2), 497–506 (2024).
Article ADS CAS PubMed MATH Google Scholar
Padawer, D. et al. Breath of Health: spectroscopy-based breath test for the detection of SARS-CoV-2. Infect Dis (Lond) 56(5), 376–383 (2024).
Article CAS PubMed Google Scholar
Denzer, W. et al. Trace species detection in the near infrared using Fourier transform broadband cavity enhanced absorption spectroscopy: Initial studies on potential breath analytes. Analyst 136(4), 801–806 (2011).
Article ADS CAS PubMed Google Scholar
Vandenplas, Y. et al. Contribution of the 13C-urea breath test to the detection of Helicobacter pylori gastritis in children. Pediatrics 90(4), 608–611 (1992).
Article CAS PubMed MATH Google Scholar
Gatta, L. et al. Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: A randomised controlled trial. Gut 55(4), 457–462 (2006).
Article ADS CAS PubMed PubMed Central MATH Google Scholar
Goddard, A. F. & Logan, R. P. Review article: Urea breath tests for detecting Helicobacter pylori. Aliment Pharmacol Ther 11(4), 641–649 (1997).
Article CAS PubMed Google Scholar
Kayali, S., et al. Non-invasive tests for the diagnosis of helicobacter pylori: state of the art. Acta Biomed., 2018. 89(8-s), 58–64.
Ulanowska, A. et al. Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. Biomed Chromatogr 25(3), 391–397 (2011).
Article CAS PubMed Google Scholar
Kushch, I. et al. On the importance of developing a new generation of breath tests for Helicobacter pylori detection. J Breath Res 9(4), 047111 (2015).
Article PubMed MATH Google Scholar
Motta, O. et al. New FTIR methodology for the evaluation of (13)C/(12)C isotope ratio in Helicobacter pylori infection diagnosis. J Infect 59(2), 90–94 (2009).
Article PubMed MATH Google Scholar
Maiti, K. S., & Apolonski, A. monitoring the reaction of the body state to antibiotic treatment against helicobacter pylori via infrared spectroscopy: A case study. Molecules, 2021. 26(11).
Li, F. et al. Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serum. Comput Struct Biotechnol J 23, 3379–3390 (2024).
Article CAS PubMed PubMed Central MATH Google Scholar
Vasapolli, R., et al. Real-time assessment of H. pylori infection to guide molecular antibiotic resistance testing: a combined endoscopy-gastric juice analysis approach. Aliment Pharmacol Ther., 2024.
Wu, H. et al. Portable and hand-held ammonia gas sensor enables noninvasive prediagnosis of helicobacter pylori infection. ACS Sens 9(10), 5384–5393 (2024).
Article CAS PubMed MATH Google Scholar
The authors would like to thank editors and the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper.
There is no funding to support this manuscript.
Meiqi Qiu and Fei Liao contributed equally to this work.
Department of Gastroenterology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan, 430060, Hubei Province, China
Meiqi Qiu, Fei Liao, Yulin Tan, Hanyu Wang & Weiguo Dong
Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, 430074, Hubei Province, China
Wuhan Gainway Technology Co., Ltd, Wuhan, 430223, Hubei Province, China
Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China
Department of Internal Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
(I) Conception and design: MQ and FL. (II) Administrative support: WD. (III) Recruitment of subjects: MQ and FL. (IV) Gas acquisition and data collection: MQ, YT, HW, HZ, WX and QX. (V) Instrument preparation and technical Support: JZ, CZ. (VI) Data analysis and interpretation: MQ, FL. (VII) Manuscript writing: all authors. (VIII) Final approval of manuscript: all authors.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Qiu, M., Liao, F., Tan, Y. et al. Application of Fourier transform infrared spectroscopy to exhaled breath analysis for detecting helicobacter pylori infection. Sci Rep 14, 31542 (2024). https://doi.org/10.1038/s41598-024-83360-0
DOI: https://doi.org/10.1038/s41598-024-83360-0
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Scientific Reports (Sci Rep) ISSN 2045-2322 (online)
air quality scale Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.